Latest news
Loading news…
Canbex Therapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). London, England, United Kingdom Founded 2005 1-10 employees For Profit
Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders.
Canbex Therapeutics was acquired by Ipsen in 2015 for $108M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 6
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2005
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- HQ
- London, England, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Feb 27, 2015
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.3
- Trend (90d)
- 5.9
Key People at Canbex Therapeutics
Head of Manufacturing
Head of Biology & Co-Founder
Head of Clinical Operations
Co-Founder
Chief Scientific Officer & Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Canbex Therapeutics
Loading news…
FAQs about Canbex Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.